The new platform helps providers to quickly evaluate the drivers of chronic and most deadly diseases. It will be used to create an appropriate plan of care that helps to find out the true cause of cardiovascular, diabetes and other chronic diseases, including inflammation.
True Health’s new tool is said to proactively identify high-risk patients and offers easier communication of complex data. It is easy to read and interpret that connects multiple inflammatory disease states.
In addition, it transfers insight into decision and action at the point of care, enabling better personalized medical management and allows information to be accessed behind the secure online portal.
True Health Diagnostics CEO Chris Grottenthaler said: "For many providers, advanced laboratory biomarkers help how they practice medicine.
"They tell us it is difficult to return to using only traditional markers. Our platform and reporting bring risk stratification and patient care to a new height. What you can identify, you can treat."
The company provides bio-markers that help healthcare providers to diagnose, manage, and prevent the progression of cardiovascular diseases, genetic disorders, diabetes and other metabolic conditions.
Image: True Health Diagnostics shows sample of personalized patient management tool. Photo: courtesy of Business Wire / True Health Diagnostics.
